Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Zolpidem for insomnia
David J. Greenblatt, Thomas Roth
Expert Opinion on Pharmacotherapy (2012) Vol. 13, Iss. 6, pp. 879-893
Closed Access | Times Cited: 266

Showing 1-25 of 266 citing articles:

Fluorination methods in drug discovery
Damian E. Yerien, Sergio M. Bonesi, Al Postigo
Organic & Biomolecular Chemistry (2016) Vol. 14, Iss. 36, pp. 8398-8427
Open Access | Times Cited: 313
The Clinical and Forensic Toxicology of Z-drugs
Naren Gunja
Journal of Medical Toxicology (2013) Vol. 9, Iss. 2, pp. 155-162
Open Access | Times Cited: 188
Regioselective Fluorination of Imidazo[1,2-a]pyridines with Selectfluor in Aqueous Condition
Ping Liu, Yongyuan Gao, Wei-Jin Gu, et al.
The Journal of Organic Chemistry (2015) Vol. 80, Iss. 22, pp. 11559-11565
Closed Access | Times Cited: 93
Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration
David J. Greenblatt, Jerold S. Harmatz, Nikhilesh Singh, et al.
The Journal of Clinical Pharmacology (2013) Vol. 54, Iss. 3, pp. 282-290
Closed Access | Times Cited: 95
A review of sleep-promoting medications used in pregnancy
Michele L. Okun, Rebecca Ebert, Bandana Saini
American Journal of Obstetrics and Gynecology (2014) Vol. 212, Iss. 4, pp. 428-441
Closed Access | Times Cited: 92
Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians
Gregory M. Asnis, Manju Thomas, Margaret Henderson
International Journal of Molecular Sciences (2015) Vol. 17, Iss. 1, pp. 50-50
Open Access | Times Cited: 90
Zolpidem’s use for insomnia
Jaime M. Monti, D. Warren Spence, Kenneth Buttoo, et al.
Asian Journal of Psychiatry (2016) Vol. 25, pp. 79-90
Closed Access | Times Cited: 69
GABA Receptors and the Pharmacology of Sleep
William Wisden, Xiao Yu, Nicholas P. Franks
Handbook of experimental pharmacology (2017), pp. 279-304
Closed Access | Times Cited: 67
Sex in Context: Limitations of Animal Studies for Addressing Human Sex/Gender Neurobehavioral Health Disparities
Lise Eliot, Sarah S. Richardson
Journal of Neuroscience (2016) Vol. 36, Iss. 47, pp. 11823-11830
Open Access | Times Cited: 62
Hypnotics in Insomnia: The Experience of Zolpidem
James Macfarlane, Charles M. Morin, Jacques Montplaisir
Clinical Therapeutics (2014) Vol. 36, Iss. 11, pp. 1676-1701
Closed Access | Times Cited: 58
Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and z-drugs consumption in nine European countries
E. Clay, Bruno Falissard, Nicholas Moore, et al.
European Journal of Clinical Pharmacology (2012) Vol. 69, Iss. 4, pp. 1-10
Open Access | Times Cited: 58
Sleep and Sedative States Induced by Targeting the Histamine and Noradrenergic Systems
Xiao Yu, Nicholas P. Franks, William Wisden
Frontiers in Neural Circuits (2018) Vol. 12
Open Access | Times Cited: 52
Zolpidem and Gender: Are Women Really At Risk?
David J. Greenblatt, Jerold S. Harmatz, Thomas Roth
Journal of Clinical Psychopharmacology (2019) Vol. 39, Iss. 3, pp. 189-199
Closed Access | Times Cited: 51
Imidazopyridine, a promising scaffold with potential medicinal applications and structural activity relationship (SAR): recent advances
Samima Khatun, Abhinav Singh, Ghulam Nabi Bader, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 24, pp. 14279-14302
Closed Access | Times Cited: 36
The position of imidazopyridine and metabolic activation are pivotal factors in the antimutagenic activity of novel imidazo[1,2-a]pyridine derivatives
Wael M. El‐Sayed, Warda A. Hussin, Yasair S. Al‐Faiyz, et al.
European Journal of Pharmacology (2013) Vol. 715, Iss. 1-3, pp. 212-218
Closed Access | Times Cited: 48
Electroencephalographic Power Spectral Density Profile of the Orexin Receptor Antagonist Suvorexant in Patients with Primary Insomnia and Healthy Subjects
Junshui Ma, Vladimir Svetnik, Ellen Snyder, et al.
SLEEP (2014) Vol. 37, Iss. 10, pp. 1609-1619
Open Access | Times Cited: 47
Zolpidem use and risk of fractures: a systematic review and meta-analysis
So-Myoung Park, Ji Kon Ryu, D. R. Lee, et al.
Osteoporosis International (2016) Vol. 27, Iss. 10, pp. 2935-2944
Closed Access | Times Cited: 45
Residual Effects of Low-Dose Sublingual Zolpidem on Highway Driving Performance the Morning after Middle-of-the-Night Use
Annemiek Vermeeren, Eric Vuurman, Tim Leufkens, et al.
SLEEP (2014) Vol. 37, Iss. 3, pp. 489-496
Open Access | Times Cited: 43
Quality Measures for the Care of Patients with Insomnia
Jack D. Edinger, Daniel J. Buysse, Ludmila V. Deriy, et al.
Journal of Clinical Sleep Medicine (2015) Vol. 11, Iss. 03, pp. 311-334
Open Access | Times Cited: 43
Bottom-Up versus Top-Down Induction of Sleep by Zolpidem Acting on Histaminergic and Neocortex Neurons
David S. Uygun, Ye Z, Anna Zecharia, et al.
Journal of Neuroscience (2016) Vol. 36, Iss. 44, pp. 11171-11184
Open Access | Times Cited: 43
Prescriber's Guide
Stephen M. Stahl
(2020)
Closed Access | Times Cited: 33
Making a ‘sex-difference fact’: Ambien dosing at the interface of policy, regulation, women’s health, and biology
Helen Hailin Zhao, Marina DiMarco, Kelsey Ichikawa, et al.
Social Studies of Science (2023) Vol. 53, Iss. 4, pp. 475-494
Open Access | Times Cited: 12
Designer benzodiazepines: an update
Yu Xiao, H. Karl Greenblatt, David J. Greenblatt
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 2, pp. 109-117
Closed Access | Times Cited: 11
Comparison of Pharmacokinetic Profiles of Zolpidem Buffered Sublingual Tablet and Zolpidem Oral Immediate-Release Tablet: Results from a Single-Center, Single-Dose, Randomized, Open-Label Crossover Study in Healthy Adults
David J. Greenblatt, Jerold S. Harmatz, Thomas Roth, et al.
Clinical Therapeutics (2013) Vol. 35, Iss. 5, pp. 604-611
Closed Access | Times Cited: 41
Age-related changes in slow wave activity rise time and NREM sleep EEG with and without zolpidem in healthy young and older adults
Evan D. Chinoy, Danielle J. Frey, Daniel N. Kaslovsky, et al.
Sleep Medicine (2014) Vol. 15, Iss. 9, pp. 1037-1045
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top